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The inhibitory effect of IgY against Vibrio parahaemolyticus
and Vibrio vulnificus responsible for seafood-borne diseases
was investigated in this study. Water-soluble fractions
(WSF) of protein containing IgYs were isolated from the
egg yolk of hens initially immunized with formalin-
inactivated V. parahaemolyticus or V. vulnificus. Protein,
total and specific IgY contents of the WSF were
determined. The inhibitory and protective effects of IgYs
on the growth of V. parahaemolyticus and V. vulnificus
were assayed in liquid medium and in mice. IgYs showed
high affinity to their corresponding antigens with high
titer from day 28 onwards. Protein contents and total IgY
concentrations remained stable throughout the immunization
period, whereas specific IgY concentrations increased
steadily and reached a plateau at day 49. Specific IgY powder
(150 mg/ml) significantly inhibited further multiplication
of both V. parahaemolyticus and V. vulnificus in liquid
medium as compared with the control IgY. The bacteria
count in mice feces was lower in mice pretreated with
specific IgYs than in those pretreated with PBS or control
IgY. Higher survival of mice was observed in the
experimental groups pretreated with either anti-V.
parahaemolyticus (75% survival) or anti-V. vulnificus
(87% survival) IgYs, compared with those in the control
groups pretreated with PBS or nonspecific IgY. All mice
in the control groups died within three days after bacteria
inoculation; hence, the protective effect of specific IgYs
against infection caused by V. parahaemolyticus and V.
vulnificus was demonstrated.
Keywords: V. parahaemolyticus, V. vulnificus, immunoglobulin
Y, in vitro, in vivo, efficacy
Microbial contamination is one of the major challenges
facing the seafood industry worldwide. Vibrio species, which
occur naturally in the estuarine and marine environment,
have been frequently isolated from seafood, seawater [16], and
vegetables [41]. They have been associated with foodborne
illnesses resulting from consumption of contaminated raw
or half-cooked seafoods such as oysters, raw fish, shell
fish, shrimps, mussels [30], and raw vegetables [41].
Vibrio parahaemolyticus was identified and documented
by the Korea Food and Drug Administration (KFDA) in
2006 as one of the leading causes of foodborne diseases in
Korea [24]. The increase in ocean surface temperatures
due to global warming has resulted in a higher prevalence
of Vibrio spp., which in return increases the risk of Vibrio
foodborne illnesses [16]. Among 12 species of Vibrio
recognized as human pathogens [33], 8 species have been
directly associated with food contamination [35]. Vibrio
parahaemolyticus, V. vulnificus, and V. cholera are the main
principle and responsible for seafood-borne illnesses in
humans [3, 5], resulting in severe intestinal diseases [20, 34].
Immunoglobulin Y (IgY) is the major low molecular
weight serum immunoglobulin in oviparous animals with
an overall structure similar to that of mammalian
immunoglobulins composed of 2 light chains and 2 heavy
chains [31]. Chicken egg yolk antibodies (IgYs) have been
applied successfully in scientific fields such as immunodiagnostics
[11, 12], food analyses in detection of toxic materials and
pathogenic microorganisms [9, 40], as well as in prophylactic
and therapeutic purposes [9, 17, 23, 25]. IgY as a natural
and food-grade antimicrobial compound can be applied in
the food industry to replace chemical preservatives to prevent
foodborne infections and enterotoxicity, thus improving
food safety. Several studies successfully elucidated the
effect of chicken IgY on the growth of various food
pathogens such as Salmonella [7, 23], Escherichia coli [42,
27, 38], Escherichia coli O157:H7 [39], vegetative and spore
forms of Clostridium perfringens [31], and Staphylococcus
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aureus [15]. However, the in vitro and in vivo effects of IgY
on Vibrio species originating from an estuarine environment
have not been addressed. Therefore, the objective of this
study was to investigate the inhibitory effect of IgY against
two Vibrio species responsible for seafood-borne diseases.
MATERIALS AND METHODS
Bacteria and Culture Conditions
Bacteria strains used included V. parahaemolyticus ATCC 17802, V.
vulnificus KCTC 2959, V. alginolyticus KCCM 40513, V.
cincinnatiensis KCCM 41683, V. fluvialis KCCM 40827, V.
mimicus KCCM 42257, Listeria monocytogenes ATCC 19111,
Salmonella typhimurium ATCC 19586, Staphylococcus aureus
ATCC 14458, Bacillus cereus ATCC 40136, and Escherichia coli
ATCC 25922. Bacteria stock suspensions in 50% glycerol and
tryptic soy broth (TSB) (Becton & Dickinson, Sparks, MD, USA) in
the ratio of 1:2 were stored at -70oC until use. 
Experimental Animals
Twelve-weeks-old single comb brown leghorns were obtained from
Sangolnongjang, Sancheong-gun, Gyeongsangnam-do, and seven-
week-old BALB/c female mice were from Hyochang Science,
Daegu, South Korea. Separately, hen and mice were maintained in
broad well-ventilated cages with wire mesh and provided with full
access to water and feed ad libitum. The room temperature was
maintained at 27±2oC and the photoperiodicity was controlled at
14 h lighting and 10 h darkness. Both animals were allowed to adapt
to the new environment for 2 weeks prior immunization. Animal
care was approved and complied with the guidelines of, the
Division of Animal Laboratories of Gyeongsang National University
Policy of Animal Care and Use.
Preparation of Immunogens
Formalin-inactivated V. parahaemolyticus and V. vulnificus, both as
immunogens for immunization and antigens for ELISA experiment,
were prepared according to a previously reported method [19].
Briefly, V. parahaemolyticus and V. vulnificus were cultured in
alkaline peptone water (APW; pH 8.6) (Becton & Dickinson, Co.)
at 37oC for 24 h, and then subcultured in fresh broth and incubated
at 37oC for 18 h. Portions of bacteria cells in each subculture were
serially diluted in sterile phosphate-buffered saline (PBS, pH 7.2)
and plated on tryptic soy agar (TSA) (Becton & Dickinson, Co.) to
determine bacteria concentrations. Immediately, the rest of the cells
were treated with 1% formalin at 37oC for 12 h. Viability of the
formalin-treated cells was checked on TSA to ensure no viable cells
persisted. Cells were harvested by centrifugation at 9,300 ×g, 4oC
for 20 min, and the pellets were washed three times with sterile
PBS. The cells concentrations were adjusted to 1.0 × 109 CFU/ml
with sterile PBS and stored at -20oC as ready-to-use immunogens.
Other Vibrio species and selected pathogenic bacteria used for cross-
reactivity studies were prepared in APW and TSB, respectively, as
described above.
Immunization of Hens
A total of 12 hens were divided into 3 groups containing 4 hens
each. The three groups were immunized as follows; the first group
with formalin-inactivated V. parahaemolyticus, the second group
with formalin-inactivated V. vulnificus, and the third (control) group
with sterile PBS. Hens were immunized according to a method
previously described [39] with slight modifications. Immunogens
(1.0 × 109 CFU/ml) were individually emulsified with an equal
volume of Freund’s complete adjuvant (Sigma, St. Louis, MO, USA)
in the first immunization and 0.25 ml per site was intramuscularly
immunized at four different sites (each upper and lower parts of the
right and left sides) of the major pectoralis (breast muscles). From
the second to the fourth immunizations, Freund’s complete adjuvant
was replaced with the Freund’s incomplete adjuvant. The fifth
immunization (booster) was performed in the same way, except that
immunogens were used alone without adjuvant. Immunizations were
carried out in 2-week intervals. Eggs from each group were
collected daily, labeled accordingly, and kept at 4oC. IgY isolation
was performed weekly.
Isolation of WSF Containing IgY and Preparation of IgY Powder
The water-soluble fraction (WSF) containing IgY was isolated from
the egg yolk using a water dilution method [1]. The egg yolks were
carefully separated from the albumin and then filtered through sterile
gauze to remove the yolk membrane. The yolks were homogenized
well, diluted 2 times with double-distilled deonized water, and then
8 volumes of 3 mM HCl (pH 3.0) was added to make a final
dilution of 1:10. The mixture was mixed well, the pH was adjusted
to 5.0 using 10% acetic acid, and then incubated at 4oC for 12 h.
After incubation, the mixture was centrifuged at 9,300 ×g, 4oC for
20 min to obtain the supernatant containing the water-soluble fraction
of protein, which was neutralized to pH 7.0 by 0.1 M NaOH, and
stored at 4oC for further experiments. The quality of the WSF of
protein containing IgY was analyzed on Tris-glycine sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under reducing
conditions using 12% resolving and 5% stacking acrylamide gels.
The gel was stained with Coomassie brilliant blue R-250 (Bio-Rad
Laboratories, Hercules, CA, USA) staining solution. The WSFs
were analyzed for activity, protein content, total and specific IgYs,
and the fraction that contained specific IgY with higher activity or
nonspecific (control) IgY was lyophilized to obtain IgY powder.
Specific Activity and Cross-Reactivity of IgYs
The activity of IgY was monitored by the enzyme linked immunosorbent
assay (ELISA) procedure optimized in a previous study [19]. The
wells of 96-well microtiter plates were coated with 100 µl of
formalin-inactivated V. parahaemolyticus or V. vulnificus at a
concentration of 108 CFU/ml in carbonate buffer (pH 9.6). Two
hundred microliter of 1% skimmed milk in PBS was used to block
the uncoated surface. One hundred microliter of anti-V. parahaemolyticus
or anti-V. vulfinicus IgYs diluted 1:1,000 in PBS was used as
primary antibody. One hundred microliter of rabbit anti-chicken IgG
conjugated with horseradish peroxidase (Sigma-Aldrich) diluted
1:10,000 in PBS was used as a secondary antibody. One hundred
microliter of 0.1 M citrate buffer (pH 4.0) containing 0.025% ABTS
and 0.03% H2O2 was used for color development. The absorbance
was measured at 405 nm using a Thermo Scientific Multiscan FC
microplate reader (Thermo Fisher Scientific, Vantaa, Finland).
For cross-reactivity studies, the anti- V. parahaemolyticus or anti-V.
vulfinicus IgYs were prepared as described above, except that the
microtiter plates were coated with formalin-inactivated cells of V.
alginolyticus, V. cincinnatiensis, V. fluvialis, V. mimicus, L.
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monocytogenes, S. typhimurium, S. aureus, B. cereus, and E. coli as
antigens to determine any binding possibilities. The cross-reactivity
was assessed by comparing the optical density obtained when the
produced IgYs were used with non-corresponding antigen coated,
with those of corresponding antigens, which were considered as
100%.
Determination of Protein, Total and Specific IgY Contents
Total protein content in the WSF and IgY powder were determined
based on the Bradford method for protein assay [6] using bovine
serum albumin (BSA) (Bio-Rad Laboratories) as a reference protein
and Bio-Rad Protein Assay Dye Reagent Concentrate. 
Based on the ELISA conditions described above and the previous
reported method [39], total and specific IgY contents were
determined using rabbit anti-chicken IgG (2.4 mg/ml) (Thermo
Scientific, Rockford, IL, USA) as a standard plate coating antigen
and purified normal chicken IgY (200 µg/0.5 ml) (Santa Cruz
Biotechnology, CA, USA) as a reference antibody. The standard
curves obtained by the titration between rabbit anti-chicken IgG and
reference purified normal chicken IgG were used to calculate the
relative concentrations of the total and specific IgYs individually.
Growth Inhibition Assay
The inhibitory activity of the produced chicken IgY on the growth
of the same strains of V. parahaemolyticus / V. vulnificus in liquid
medium was performed according to a method reported [38].
Bacteria were grown in APW at 37oC, 150 rpm for 18 h, and the
optical density at 600 nm using UV spectrophotometer (UV-1601,
SHIMADZU Corporation, Kyoto, Japan) was adjusted to 0.07 and
0.20 for V. parahaemolyticus and V. vulnificus, respectively, which
corresponded to 1.0 × 106 CFU/ml. The same volume of 20%
glycerol in APW was added and stored at -70oC until used.
Two milliliters of the above-prepared bacteria suspension was
mixed with an equal volume of APW and incubated at 37oC,
150 rpm, and the absorbance of the culture was measured at 30 min
intervals for the first 5 h and then at 1 h intervals to attain 12 h and
at 2 h intervals to attain 24 h. The growth curve was plotted and
used to determine the sampling time for the growth inhibition assay.
IgY powders were reconstituted in sterile APW to a final
concentrations of 100, 200, and 300 mg/ml. After a thorough mixing,
the contents were centrifuged at 1,600 ×g and then the supernatant
was aseptically filtered using a 0.20 µm membrane filter (Sartorius
Stedim Biotech, Goettingen, Germany). Two milliliters of the sterile
specific or nonspecific IgY solutions was separately mixed with
2 ml of the prepared bacteria culture, and the mixture was incubated
at 37oC, 150 rpm. Aliquots of 100 µl were taken after every 2 h for
12 h of incubation for viable bacteria count, performed in duplicate
on TSA plates. TSA plates were incubated at 37oC overnight to
determine the actual bacteria count.
Protective Effect of IgY Against V. parahaemolyticus and V.
vulnificus Infection in Mice
Specific and nonspecific IgY powders were dissolved in sterile PBS
to a final concentration of 300 mg/ml, centrifuged at 1,600 ×g, and
then the supernatant was aseptically filtered using a 0.20 µm membrane
filter. BALB/c mice were divided into two groups, and from each of
the two groups, subgroups of eight mice were orally administered with
0.5 ml of sterile PBS, control (nonspecific) IgY, anti-V. parahaemolyticus
IgY, or anti-V. vulnificus IgY solutions, respectively. IgY solutions
and PBS were administered via oral gavages using a blunt round-
ended flexible stainless steel needle connected to a syringe. After an
hour, mice in the first group were orally inoculated with 50 µl
(1.0 × 107 CFU/ml) of V. parahaemolyticus and those in the second
group with V. vulnificus cells suspensions in PBS. All mice were
transferred to clean cages and fecal shedding from each group was
separately collected within 12 h after inoculation. One gram of fecal
samples was suspended in 9 ml of sterile PBS and viable bacteria
count was determined by the spread plate technique on heart
infusion (HI) agar (Becton, Dickinson, Co.) as previously described
[32]. Plates were incubated at 37oC for 18 h. Furthermore, mice
survival was monitored for 7 days following bacteria inoculation.
Statistical Analysis
Analysis of variance (ANOVA), a component of Statistics to use
[21], was used to analyze the results. Student’s t-tests were utilized
to test the significance differences between the antibody titer of the
control and experimental groups, cross-reactivity of specific antibodies
to other pathogenic bacteria and other Vibrio species, protein contents,
total and specific IgY concentration. Data were presented as means
± standard deviations. A probability of p < 0.05 was considered
statistically significant.
RESULTS 
Production of Specific IgY in Hens
Formalin-inactivated V. parahaemolyticus and V. vulnificus
immunogens were used for immunization of hens. Both
immunogens produced high immugenicity to the immunized
hens. The WSF obtained from the egg yolks of both V.
parahaemolyticus and V. vulnificus immunized hens
resulted into a short lag phase seen in the first week of
immunization, followed by a rapid response shown by an
increase in specific IgY activity at the second week. This
exponential increase of specific IgY in the second week
was maintained for a further two weeks, the peak was
reached at the fourth week of immunization and the titer
Fig. 1. Profile of IgY activity (1:1,000) from hens immunized
with either formalin-inactivated V. parahaemolyticus or V.
vulnificus in comparison with the control group immunized with
sterile PBS. 
For control IgY on the graph legend, the organisms in parentheses indicate
coating antigen used. Immunization days are marked with ∆.
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was maintained more or less constant for about six weeks
regardless of the booster immunization given at the 8th
week. The antibody levels of the immunized hens were
significantly higher than those of the controls (p < 0.05)
for both V. parahaemolyticus and V. vulnificus immunized
hens (Fig. 1). There was no significant difference in the
IgY titer (p > 0.05) of the WSF obtained from the egg
yolks of hens immunized with V. parahaemolyticus or V.
vulnificus immunogens.
The quality of the isolated WSF of protein containing
IgY is presented with two major bands at about 68 and
25 kDa as the heavy and light chains of IgY, respectively, for
both fractions obtained from immunized (specific IgYs)
and control (nonspecific IgYs) hens (Fig. 2). Minor bands
imply other proteins contained in the WSF, which can be
omitted by further purification of IgY from the fraction.
Determination of Protein, Total and Specific IgY Contents
in the WSF
The isolated WSF of protein from egg yolk throughout the
immunization period was characterized by the determination
of protein content, total and specific IgYs. The protein and
total IgY concentrations remained more or less stable
throughout the immunization period. There was no significant
increase in protein and total IgY contents (p > 0.05) in egg
yolk throughout the immunization period for hens immunized
with V. parahaemolyticus or V. vulnificus immunogens.
The protein and total IgY contents of unimmunized hens
was also similar to those of the immunized hens. The
average protein contents were found to be 30.30 ± 0.61
and 32 ± 1.30 mg/ml of egg yolk for WSF obtained from
the egg yolk of hens immunized with V. parahaemolyticus
and V. vulnificus, respectively. The average total IgY
contents were 25.11 ± 2.28 and 21.07 ± 2.18 mg/ml of egg
yolk for WSF obtained from the egg yolk of hens
immunized with V. parahaemolyticus and V. vulnificus,
respectively.
The specific IgY content of the WSF significantly
increased (p < 0.05) with the increase in immunization
period for both V. parahaemolyticus and V. vulnificus
immunized hens, with the highest concentration reached at
day 49 from the first immunization and was maintained
constant for a further three weeks of observation. The increase
in concentration of the specific IgY was independent to the
constant contents of protein and total IgY. The highest
concentrations of specific IgY were 2.36 ± 0.36 and
2.74 ± 0.22 mg/ml of egg yolk for WSF obtained from the
egg yolk of hens immunized with V. parahaemolyticus and
V. vulnificus, respectively (Fig. 3). This may imply the
point at which the maximum conversion of nonspecific
IgY to specific IgY may have been reached.
Specific Activity and Cross Reactivity of IgY
To determine the immunoreactivity and specificity of the
IgYs in the isolated WSF, indirect ELISA was used. Both
anti-V. parahaemolyticus and anti-V. vulnificus IgYs
resulted in high affinity to their corresponding plate-coated
formalin-inactivated V. parahaemolyticus and V. vulnificus
antigens. The WSF obtained by 1:10 dilution of the egg
yolk presented significantly high sensitive IgYs at a
dilution of 1:500. Therefore, both immunogens resulted in
a highly sensitive IgY at a total dilution of 1:5,000 of the
egg yolk.
Fig. 2. SDS-PAGE results of WSF of protein containing IgY
from chicken egg yolk. 
Protein marker (lane 1); WSF obtained from control chicken (lane 2),
chicken immunized with V. parahaemolyticus (lane 3), and those
immunized with V. vulnificus (lane 4), formalin-inactivated cells.
Fig. 3. Specific IgYs concentrations in the WSF obtained from
egg yolks of hens immunized with V. parahaemolyticus and V.
vulnificus immunogens throughout the immunization period.
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The cross-reactivity studies showed a moderate cross
reaction between both anti-V. parahaemolyticus and anti-V.
vulnificus IgYs to other Vibrio species tested. In the case of
anti-V. parahaemolyticus IgY, a cross-reactivity of 68.55%,
69.85%, 65.46%, 55.28%, and 54.92% was obtained with
V. vulnificus, V. alginolyticus, V. cincinnatiensis, V. fluvialis,
and V. mimicus, respectively, whereas for anti-V. vulnificus
IgY, a cross reactivity of 46.17%, 50.46%, 52.42%, 35.81%,
and 39.59% was obtained with V. parahaemolyticus, V.
alginolyticus, V. cincinnatiensis, V. fluvialis, and V. mimicus,
respectively. When the cross-reactivity of both IgYs was
tested against the selected pathogenic bacteria, a relatively
low cross-reactivity of less than 40% was observed for all
bacteria tested.
Growth Inhibitory Activity of IgYs 
The growth inhibitory effects of IgYs on V. parahaemolyticus
and V. vulnificus were assessed in liquid medium. Under
the same conditions as those used to obtain growth curve,
which was used to determine the sampling time, V.
parahaemolyticus and V. vulnificus were cultured and
incubated separately with either their corresponding
specific or nonspecific IgYs powder at concentrations of
Fig. 4. Effects of different concentrations [(A) 50 mg/ml, (B)
100 mg/ml, and (C) 150 mg/ml] of anti-V. parahaemolyticus IgY
powder on the growth of V. parahaemolyticus in liquid medium. 
Negative control (no IgY used); control IgY (nonspecific IgY was used).
Fig. 5. Effects of different concentrations [(A) 50 mg/ml, (B)
100 mg/ml, and (C) 150 mg/ml] of anti-V. vulnificus IgY powder
on the growth of V. vulnificus in liquid medium. 
Negative control (no IgY used); control IgY (nonspecific IgY was used).
EFFICACY OF IGY ON V. PARAHAEMOLYTICUS AND V. VULNIFICUS 1428
50, 100, and 150 mg/ml. As shown in Fig. 4 and 5, the
incubation of bacteria with 50 mg/ml IgY solution did not
inhibit the growth of both V. parahaemolyticus and V.
vulnificus as the number of bacteria count in the control and
experimental groups were similar. Increasing the concentration
of IgY powder to 100 mg/ml resulted in a decrease in
viable cell count of the experimental group after 6 h of
incubation for V. parahaemolyticus and after 4 h for V.
vulnificus and no effect was observed in the control group
throughout the incubation time. A further increase in IgY
concentration to 150 mg/ml in the incubation mixture
resulted in a further decrease in viable cell count of the
experimental group, and no effect was observed in the control
group for both V. parahaemolyticus and V. vulnificus.
Therefore, the inhibitory effect of specific IgY powder on
the growth of V. parahaemolyticus and V. vulnificus was
dose-dependent. The presence of different concentrations
(50, 100, and 150 mg/ml) of nonspecific IgY powder in the
incubation mixture did not have any effect on the growth
of bacteria, as the growth pattern in these groups was
similar to those incubated in the absence of IgY.
Effect of IgY on V. parahaemolyticus and V. vulnificus
in Mice
When the protective effect of specific IgY against V.
parahaemolyticus and V. vulnificus infection was examined in
mice, fecal shedding of bacteria revealed a significant reduction
in the number of bacterial count in mice pre-treated with
specific IgYs compared with the control groups (Fig. 6A
and 6B). Fecal shedding of bacteria in the control groups
pre-treated with either PBS or nonspecific IgYs was found
to be similar in both V. parahaemolyticus and V. vulnificus
infected mice. A further monitoring of mice survival for
seven days following bacteria inoculation showed higher
survival of mice in the experimental groups pre-treated
with either anti-V. parahaemolyticus (75% survival) or
anti-V. vulnificus (87% survival) IgYs, compared with
those in the control groups pre-treated with PBS or
nonspecific IgY. High death rates were encountered in the
control mice, and all were dead within three days after
bacteria inoculation (Fig. 7A and 7B). This suggests that
specific IgYs have a protective effect against infection
caused by V. parahaemolyticus and V. vulnificus, and hence
increase the survival of the host animal.
DISCUSSION
Several studies have been done to explore the usefulness of
avian immunoglobulin Y in food, drug, microbial, and
Fig. 6. Fecal shedding of (A) V. parahaemolyticus and (B) V.
vulnificus in orally infected mice pre-treated with PBS, control,
or specific IgYs.
Fig. 7. Survival of mice orally inoculated with (A) V.
parahaemolyticus or (B) V. vulnificus after pre-treatment with
PBS, control, or specific IgYs.
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residual analyses [2, 36, 40], immunodiagnostics [11, 12],
passive immunization, and therapeutic functions [9, 17, 23,
25]. The advantages of using avians such as chicken and
quails as a source of immunoglobulins have also been
narrated [10, 13, 14, 18, 22]. Based on the previous study
[19], chicken egg yolk antibodies targeting V. parahaemolyticus
and V. vulnificus were produced. The analysis of the WSF
of the egg yolk protein on SDS-PAGE resulted into two
main bands as heavy and light chains of IgY, along with
minor bands of other proteins contained in the fraction.
These minor proteins could be omitted by further
purification of IgY from the fraction. However, for the
purpose of this work, the crude protein extract was sufficient
for the subsequent experiments on the antibacterial effect
of IgY, and hence averting further addition of chemicals in
the mixture, which could have a negative impact on the in
vitro and in vivo assays. In other related studies, 2 bands of
heavy and light chains of both chicken and quail IgYs at
the same molecular weights on SDS-PAGE analysis under
reducing conditions were obtained [4, 19].
The titer of the specific antibody produced in immunized
hens increase rapidly from the second week and reached a
peak at the fourth week and was maintained stable for a
further six weeks of observation, regardless of the booster
immunization being given at the 8th week. At this point, the
conversion of nonspecific to specific IgY might have
reached a maximum; however, the booster immunization
might have supported the stability phenomenon observed
from the 4th to the 10th weeks of observation. This rapid
increase in antibody titer implies a quick immune response
in immunized hens. The stability of IgY titer potentiates a
longer period and subsequently a large quantity of antibody
can be harvested from hens. When the same immunogens
were used to produce IgY in quail, a relatively slow
immuneresponse and instability of the IgY titer were observed
[19], signifying that hens may be of more advantage if a
large amount of antibody needs to be harvested for further
applications, such as for passive immunization, therapeutic
or prophylactic purposes.
The protein and total IgY contents of the WSF were
found to be similar in both control and immunized hens,
and it was maintained almost stable throughout the
immunization period. The concentrations of protein and
total IgY were not influenced by the immunization
schedule, but rather by the isolation process, which may
have resulted in minor differences from one isolation batch
to another. These analogous findings of similar concentrations
of protein and total IgY in control and experimental
animals throughout the immunization period have also
been reported [23, 38, 39]. Irrespective of the constant
concentrations of protein and total IgY, specific IgY in the
same WSF increased with the increase in immunization
period to day 49, where the peak was reached and maintained
constant. This signifies that the amounts of protein and
total IgY are not influenced by immunization, whereas the
specific IgY is initiated and increased with immunization.
The produced IgYs were highly sensitive to their
corresponding antigens, demonstrated by a dilution of
1:5,000 on ELISA. A relatively high specificity was
observed when the affinity of both IgYs was tested with
other pathogenic bacteria including L. monocytogenes, S.
aureus, S. typhimurium, B. cereus, and E. coli. However,
when the specificity of the IgYs was tested against other
Vibrio species including V. alginolyticus, V. cincinnatiensis,
V. fluvialis, and V. mimicus, anti-V. parahaemolyticus IgY
demonstrated a cross-reactivity of up to 69.85%, whereas
anti-V. vulnificus IgY showed a relatively low cross-
reactivity of up to 52.42%. The observed cross-reactivity
might have been attributed by similarities in the V.
parahaemolyticus and V. vulnificus epitopes with those of
other Vibrio spp. tested.
The bactericidal and bacteriostatic effects of specific
IgYs has been associated with a mechanism of antibody to
opsonize bacteria for phagocytosis or activation of compliment
for lysis as well as the ability of antibody to inhibit growth
or killing of bacteria [8, 15, 17, 27]. The prepared specific
IgY powder showed a significant antibacterial activity on
the growth of V. parahaemolyticus and V. vulnificus. The
dose-dependent pattern of the antibacterial effect observed
in this study is supported by similar findings on other
pathogenic bacteria such as E. coli [38, 39, 42], Salmonella
spp. [7, 39] Staphylococcus aureus [15], and Streptococcus
mitis [28]. These findings substantiate the potential use of
IgY in food applications, owing to its ability to inhibit or
neutralize pathogenic activities associated with infectious
diseases. The protective effect of specific IgY against V.
parahaemolyticus and V. vulnificus infection was demonstrated
in mice. A reduction in the number of colony forming units
in experimental mice feces compared with those of the
control groups was observed. Furthermore, mice survival
was higher in the experimental group compared with the
control for both V. parahaemolyticus and V. vulnificus
infected mice. Similar findings on the protective effect of
specific IgY against V. cholerae infection in suckling mice
[17] and Yersinia ruckeri infection in rainbow trout [25]
have been reported. These findings are supported by the
previous findings that suggested the possible use of
specific IgYs as alternative antibiotics [37] and preservatives.
In conclusion, the produced IgYs showed a good titer
with high reactivity to their corresponding antigens. The
protein and total IgYs contents were not influenced by the
immunization schedule, whereas the specific IgYs increased
with immunization. IgYs showed a significant inhibitory
effect on the growth and multiplication of V. parahaemolyticus
and V. vulnificus both in liquid medium and in the mice
model. Having an essential antibacterial effect both in vitro
and in vivo, IgYs can be used as an alternative antibiotic or
an oral immunotherapeutic agent against Vibrio-associated
EFFICACY OF IGY ON V. PARAHAEMOLYTICUS AND V. VULNIFICUS 1430
foodborne illnesses. Moreover, in food industries, IgYs
can be used as an alternative to chemical preservatives to
prevent further multiplication of Vibrio spp.
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